We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+6.7%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.42B
AUM Growth
+$395M
(+4.9%)
Cap. Flow
+$387M
Cap. Flow
% of AUM
4.59%
Top 10 Holdings %
Top 10 Hldgs %
13.3%
Holding
2,480
New
199
Increased
650
Reduced
579
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$19.3M |
| 2 |
Altria Group
MO
|
+$15.9M |
| 3 |
WisdomTree Emerging Markets High Dividend Fund
DEM
|
+$14.8M |
| 4 |
Wintrust Financial
WTFC
|
+$10M |
| 5 |
Automatic Data Processing
ADP
|
+$9.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
| 2 |
Procter & Gamble
PG
|
+$12.3M |
| 3 |
ExxonMobil
XOM
|
+$11.6M |
| 4 |
Nu Skin
NUS
|
+$9.69M |
| 5 |
TUP
Tupperware Brands Corporation
TUP
|
+$9.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.93% |
| 2 | Industrials | 13.23% |
| 3 | Financials | 11.33% |
| 4 | Healthcare | 11.29% |
| 5 | Consumer Staples | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Gilead Sciences
GILD
$161B
| $9.62M | 0.11% |
153,091
+30,148
| +25% | +$1.8M |
|
227
Prosperity Bancshares
PB
$8.77B
| $9.57M | 0.11% |
154,179
-43,562
| -22% | -$2.59M |
|
|
AET
228
DELISTED
Aetna Inc
AET
| $9.52M | 0.11% |
148,743
-8,063
| -5% | -$517K |
|
229
Eastman Chemical
EMN
$7.8B
| $9.51M | 0.11% |
122,160
-3,332
| -3% | -$257K |
|
|
STSA
230
DELISTED
STERLING FINL CORP (WA) COM NEW
STSA
| $9.49M | 0.11% |
321,522
-59,989
| -16% | -$1.59M |
|
|
QCOR
231
DELISTED
QUESTCOR PHARMA INC
QCOR
| $9.46M | 0.11% |
164,681
+21,929
| +15% | +$1.3M |
|
232
iShares Core S&P Small-Cap ETF
IJR
$109B
| $9.38M | 0.11% |
188,000
+3,528
| +2% | +$170K |
|
233
GSK
GSK
$103B
| $9.36M | 0.11% |
149,263
-3,183
| -2% | -$205K |
|
234
Entegris
ENTG
$19.7B
| $9.33M | 0.11% |
899,791
+268,154
| +42% | +$2.59M |
|
235
AGCO
AGCO
$8.78B
| $9.32M | 0.11% |
154,312
+68,985
| +81% | +$3.91M |
|
236
AZZ Inc
AZZ
$4.5B
| $9.29M | 0.11% |
216,536
+29,775
| +16% | +$1.15M |
|
237
APA Corp
APA
$12.8B
| $9.25M | 0.11% |
108,671
-4,738
| -4% | -$394K |
|
238
Southwest Airlines
LUV
$22.1B
| $9.13M | 0.11% |
627,105
-9,605
| -2% | -$131K |
|
|
AFSI
239
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $9.13M | 0.11% |
479,972
+65,195
| +16% | +$1.21M |
|
|
PMT
240
PennyMac Mortgage Investment
PMT
$849M
| $9.02M | 0.11% |
396,922
+55,602
| +16% | +$1.21M |
|
241
McKesson
MCK
$98.5B
| $8.98M | 0.11% |
70,032
-8,860
| -11% | -$1.09M |
|
242
Booking.com
BKNG
$138B
| $8.98M | 0.11% |
222,075
+2,400
| +1% | +$89.8K |
|
243
Myriad Genetics
MYGN
$530M
| $8.92M | 0.11% |
385,391
+115,983
| +43% | +$3.3M |
|
|
RPT
244
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $8.79M | 0.1% |
568,781
+167,022
| +42% | +$2.57M |
|
245
Jack Henry & Associates
JKHY
$10.7B
| $8.76M | 0.1% |
169,581
+9,265
| +6% | +$463K |
|
246
Bank of America
BAC
$435B
| $8.74M | 0.1% |
633,877
-21,328
| -3% | -$304K |
|
247
United Therapeutics
UTHR
$26.3B
| $8.71M | 0.1% |
110,550
+54,928
| +99% | +$4.01M |
|
248
Biogen
BIIB
$29.9B
| $8.71M | 0.1% |
36,170
-677
| -2% | -$152K |
|
249
Sabra Healthcare REIT
SBRA
$5.64B
| $8.68M | 0.1% |
369,427
+125,870
| +52% | +$3.1M |
|
250
CSX Corp
CSX
$98.6B
| $8.65M | 0.1% |
1,008,186
+53,625
| +6% | +$450K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2013 Portfolio in Review
As of Q3 2013, Glenmede Trust held 2,480 positions worth $8.42B, up 4.9% from $8.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Glenmede Trust deployed $387M of net new capital in Q3 2013, opening 199 new positions and adding to 650 existing holdings. Its largest new stake was WisdomTree Emerging Markets High Dividend Fund: 294,160 shares worth $15.2M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $18.5M trimmed.
- Glenmede Trust's largest Q3 2013 buy was WisdomTree Emerging Markets High Dividend Fund: 294,160 shares worth $15.2M.
- Glenmede Trust added most to Vanguard FTSE Developed Markets ETF in Q3 2013, an estimated $19.3M increase.
- Glenmede Trust's biggest Q3 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $18.5M.
- Glenmede Trust fully exited PacWest Bancorp in Q3 2013, selling an estimated $9.3M.
- Glenmede Trust's ten largest holdings make up 13% of its $8.42B portfolio in Q3 2013.
- Glenmede Trust opened 199 new positions and closed 158 in Q3 2013.
- Glenmede Trust's portfolio value rose 4.9% quarter-over-quarter to $8.42B.
Based on Glenmede Trust's 13F filing for Q3 2013, filed 14 Nov 2013.